Coya Therapeutics, Inc. (COYA) financial statements and ratios from SEC XBRL: revenue $7.95M (TTM), net margin -267.1%, revenue growth 123.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $7.95M |
| Net Margin | -267.1% |
| Revenue Growth (YoY) | 123.6% |
| EPS Growth (YoY) | 29.6% |
| Price / Book | 2.63 |
| Price / Sales | 26.45 |
| Altman Z-Score | 7.87 (safe) |
| Sector P/E (Healthcare) | 21.7 |
COYA overview · COYA earnings · COYA KPIs · COYA investor relations · COYA ownership · COYA peers · COYA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.